{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:20:37Z","timestamp":1794086437760,"version":"4.8.0"},"reference-count":147,"publisher":"European Respiratory Society (ERS)","issue":"160","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,12,26]]},"published-print":{"date-parts":[[2021,6,30]]},"abstract":"<jats:p>There is no consensus on how best to measure responses to interventions among children and adults with cystic fibrosis (CF). We have systematically reviewed and summarised the characteristics and measurement properties of tests and tools that have been used to capture outcomes in studies among people with CF, including their reliability, validity and responsiveness. This review is intended to guide researchers when selecting tests or tools for measuring treatment effects in CF trials. A consensus set of these tests and tools could improve consistency in how outcomes are captured and thereby facilitate comparisons and synthesis of evidence across studies.<\/jats:p>","DOI":"10.1183\/16000617.0354-2020","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T08:00:23Z","timestamp":1620806423000},"page":"200354","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review"],"prefix":"10.1183","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-7493","authenticated-orcid":false,"given":"Charlie","family":"McLeod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"2024102403540491000_30.160.200354.1","unstructured":"Curtis L , Hernandez A , Weinfurt K . Choosing and Specifying Outcomes and Endpoints. Section 1, Introduction. In: NIH Collaboratory Living Textbook of Pragmatic Clinical Trials. Bethesda, MD, NIH, 2020."},{"key":"2024102403540491000_30.160.200354.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.103.2684.677"},{"key":"2024102403540491000_30.160.200354.3","unstructured":"Eisenstein E , Anstrom K , Zozus M , et al. Choosing and Specifying Outcomes and Endpoints. Section 5, Inpatient endpoints in pragmatic clinical trials. In: NIH Collaboratory Living Textbook of Pragmatic Clinical Trials. Bethesda, MD, NIH, 2020"},{"key":"2024102403540491000_30.160.200354.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.02.006"},{"key":"2024102403540491000_30.160.200354.5","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta2140","article-title":"Evaluating patient-based outcome measures for use in clinical trials","volume":"2","author":"Fitzpatrick R","year":"1998","journal-title":"Health Technol Assess"},{"key":"2024102403540491000_30.160.200354.6","unstructured":"World Health Organization. WHOQOL: Measuring Quality of Life 2020. www.who.int\/healthinfo\/survey\/whoqol-qualityoflife\/en\/ Date last updated: 12 March 2021; date last accessed: 8 August 2020."},{"key":"2024102403540491000_30.160.200354.7","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23256"},{"issue":"Suppl. 2","key":"2024102403540491000_30.160.200354.8","first-page":"419","article-title":"Quality of life in patients with CF using three online research questionnaires: a feasibility study","volume":"54","author":"Archangelidi","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206260.335"},{"key":"2024102403540491000_30.160.200354.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.rti.0000203937.82276.ce"},{"key":"2024102403540491000_30.160.200354.11","unstructured":"Bullinger M , Petersen C , Muehlan H , et al. A European approach to measuring quality of life in children with chronic conditions: the DISABKIDS experience. Psychother Psychosom 2013; 82: 14."},{"issue":"Suppl. 2","key":"2024102403540491000_30.160.200354.12","first-page":"355","article-title":"Alfred wellness score: effects of pulmonary exacerbations on adult CF patient-reported outcomes-stability and validity","volume":"54","author":"Button","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.13","first-page":"P3371","article-title":"Comparative study of three quality of life instruments in adolescents and adults with cystic fibrosis","volume":"40","author":"Cebrian","year":"2012","journal-title":"Eur Respir J"},{"key":"2024102403540491000_30.160.200354.14","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.570"},{"key":"2024102403540491000_30.160.200354.15","first-page":"435","article-title":"Development of the pictorial preschool cystic fibrosis questionnaire-revised: child and parent report","volume":"49","author":"Cheney","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.16","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2001.1194"},{"issue":"Suppl. 1","key":"2024102403540491000_30.160.200354.17","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1569-1993(19)30573-9","article-title":"The development and use of a pancreatic exocrine insufficiency questionnaire to assess symptoms and their impacts in cystic fibrosis","volume":"18","author":"Connett","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2006.01.005","article-title":"Fecal elastase-1: utility in pancreatic function in cystic fibrosis","volume":"5","author":"Daftary","year":"2006","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057512"},{"issue":"Suppl. 1","key":"2024102403540491000_30.160.200354.20","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1569-1993(19)30129-8","article-title":"The Modified Shuttle Test to predict survival in cystic fibrosis","volume":"18","author":"Doeleman","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 3","key":"2024102403540491000_30.160.200354.21","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S1569-1993(18)30435-1","article-title":"The minimal clinically important difference for survival in patients with cystic fibrosis","volume":"17","author":"Doeleman","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.619"},{"key":"2024102403540491000_30.160.200354.23","first-page":"308","article-title":"Validation of a nitrogen (N2) based multiple breath washout technology in healthy children and children with cystic fibrosis","volume":"47","author":"Gibney","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.24","first-page":"287","article-title":"Validation of sweat gland potential difference measurements as a practical in vivo method of assessing CFTR function","volume":"46","author":"Gonska","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.25","first-page":"294","article-title":"Advancing patient reported outcomes in children with cystic fibrosis","volume":"46","author":"Goss","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.26","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20376"},{"key":"2024102403540491000_30.160.200354.27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0352"},{"issue":"Suppl. 3","key":"2024102403540491000_30.160.200354.28","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1569-1993(18)30134-6","article-title":"Comparing abdominal symptoms in cystic fibrosis patients and healthy controls with a novel multimodal questionnaire (CF-Abd Score)","volume":"17","author":"Jaudszus","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.29","unstructured":"Lowman JD , Moore K , Peeples A , et al. Reliability of musculoskeletal outcome measures. Pediatr Pulmonol 2010; 33: 387."},{"key":"2024102403540491000_30.160.200354.30","first-page":"341","article-title":"To believe or not to believe first pulmonary function test in cystic fibrosis patients","volume":"46","author":"Madan Kumar","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 1","key":"2024102403540491000_30.160.200354.31","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1569-1993(19)30221-8","article-title":"Validity and reliability of a novel multimodal questionnaire for the assessment of abdominal symptoms in people with cystic fibrosis (CFAbd-Score)","volume":"18","author":"Mainz","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10092004"},{"key":"2024102403540491000_30.160.200354.33","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13355299"},{"issue":"Suppl. 45","key":"2024102403540491000_30.160.200354.34","first-page":"469","article-title":"Parent and child differences in psychosocial symptom reporting","volume":"51","author":"Mayersohn","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.35","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsg044"},{"key":"2024102403540491000_30.160.200354.36","first-page":"354","article-title":"Systematic review of field exercise testing in cystic fibrosis \u2013 reliability and validity","volume":"46","author":"Moran","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.37","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/ppul.24149","article-title":"Alternate gas washout indices: assessment of ventilation inhomogeneity in mild to moderate pediatric cystic fibrosis lung disease","volume":"53","author":"Nyilas","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.38","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsn038"},{"key":"2024102403540491000_30.160.200354.39","doi-asserted-by":"crossref","first-page":"A288","DOI":"10.1016\/j.jval.2015.03.1680","article-title":"Quality of life in adult patients with cystic fibrosis \u2013 a systematic review","volume":"18","author":"Parekh","year":"2015","journal-title":"Value Health"},{"key":"2024102403540491000_30.160.200354.40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1207\/s15326888chc3402_3","article-title":"A tool to individualize nutritional care for children with cystic fibrosis: reliability, validity, and utility of the CF Individualized NuTritional Assessment of Kids Eating (CF INTAKE)","volume":"34","author":"Powers","year":"2005","journal-title":"Child Health Care"},{"issue":"Suppl. 47","key":"2024102403540491000_30.160.200354.41","first-page":"453","article-title":"Psychometric analyses of a new GI symptom tracker for cystic fibrosis","volume":"52","author":"Quittner","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.42","first-page":"A1176","article-title":"Health-related quality of life in adolescents with cystic fibrosis: associations with age, gender, nutrition and pulmonary function","volume":"201","author":"Quittner","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403540491000_30.160.200354.43","first-page":"419","article-title":"Content validity of the cystic fibrosis questionnaire-revised (CFQ-R)","volume":"46","author":"Quittner","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 1","key":"2024102403540491000_30.160.200354.44","first-page":"41","article-title":"Development of the preschool cystic fibrosis questionnaire-revised (CFQ-R)","volume":"24","author":"Quittner","year":"2015","journal-title":"Qual Life Res"},{"key":"2024102403540491000_30.160.200354.45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000493323","article-title":"Comparison of nocturnal cough analysis in healthy subjects and in patients with cystic fibrosis and primary ciliary dyskinesia: a prospective observational study","volume":"97","author":"Radine","year":"2019","journal-title":"Respiration"},{"key":"2024102403540491000_30.160.200354.46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.resp.2018.04.006","article-title":"The many ways sputum flows \u2013 dealing with high within-subject variability in cystic fibrosis sputum rheology","volume":"254","author":"Radtke","year":"2018","journal-title":"Respir Physiol Neurobiol"},{"key":"2024102403540491000_30.160.200354.47","doi-asserted-by":"crossref","first-page":"eS931","DOI":"10.1016\/j.physio.2015.03.1777","article-title":"New incremental field step-test (iStep) is valid and feasible in measuring near maximal exercise performance in children with cystic fibrosis","volume":"101","author":"Rand","year":"2015","journal-title":"Physiotherapy"},{"issue":"Suppl. 58","key":"2024102403540491000_30.160.200354.48","first-page":"3446","volume":"44","author":"Rosenow","year":"2014","journal-title":"Eur Respir J"},{"key":"2024102403540491000_30.160.200354.49","first-page":"340","article-title":"Quantitation of chest CT abnormalities in early life CF: back to the basics","volume":"48","author":"Rosenow","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.50","first-page":"295","article-title":"PRAGMA: further support for use as a quantitative CT outcome measure","volume":"49","author":"Rosenow","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.rmed.2019.03.019","article-title":"Activity monitors in pulmonary disease","volume":"151","author":"Sehgal","year":"2019","journal-title":"Respir Med"},{"key":"2024102403540491000_30.160.200354.52","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06224"},{"key":"2024102403540491000_30.160.200354.53","first-page":"A133","article-title":"Finding meaning in illness: development and initial validation of a measure of sense-seeking and sense-making","volume":"3","author":"Sherman AC","year":"2013","journal-title":"Psychosom Med"},{"key":"2024102403540491000_30.160.200354.54","first-page":"A11118","article-title":"Correlation of a semi-quantitative lung magnetic resonance imaging score with baseline FEV1 in cystic fibrosis","volume":"183","author":"Taylor-Cousar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403540491000_30.160.200354.55","first-page":"441","article-title":"Assessment using e-health technologies in pediatric cystic fibrosis: developing a CF-specific module for the quality of life systemic inventory for children (QLSI-C)-iPad version","volume":"49","author":"Toucheque","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 1","key":"2024102403540491000_30.160.200354.56","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S1569-1993(19)30723-4","article-title":"Validation of an electronic version of the Cystic Fibrosis Quality of life Evaluative Self-administered Test (eCF-QUEST)","volume":"18","author":"Tullis","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 45","key":"2024102403540491000_30.160.200354.57","first-page":"187","article-title":"Field exercise tests: which ones, and what can they tell you?","volume":"51","author":"Von Berg","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.58","unstructured":"Ward N , Stiller K , Rowe H , et al. Assessment of cough in cystic fibrosis. Respirology 2016; 21: Suppl. 2, 168."},{"key":"2024102403540491000_30.160.200354.59","doi-asserted-by":"crossref","first-page":"A286","DOI":"10.1016\/j.jval.2015.03.1669","article-title":"Understanding the suitability of cystic fibrosis-specific clinical outcome assessments for clinical trials and to support medical product labeling","volume":"18","author":"Willgoss","year":"2015","journal-title":"Value Health"},{"issue":"Suppl. 3","key":"2024102403540491000_30.160.200354.60","first-page":"S19","article-title":"Psychometric validation of a patient-reported outcome questionnaire in patients with pancreatic exocrine insufficiency","volume":"17","author":"Williamson","year":"2017","journal-title":"Pancreatology"},{"key":"2024102403540491000_30.160.200354.61","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/MPG.0000000000001366","article-title":"Comparison of nasal potential difference and intestinal current measurements as surrogate markers for CFTR function","volume":"63","author":"Wilschanski","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024102403540491000_30.160.200354.62","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10043"},{"key":"2024102403540491000_30.160.200354.63","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF03040902","article-title":"Cystic fibrosis and lung transplantation \u2013 determination of the survival benefit","volume":"116","author":"Aigner C","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"2024102403540491000_30.160.200354.64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcf.2014.11.002","article-title":"Initial evaluation of the Parent Cystic Fibrosis Questionnaire-Revised (CFQ-R) in infants and young children","volume":"14","author":"Alpern","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rmed.2018.02.016","article-title":"Six-minute walk test as a determinant of the functional capacity of children and adolescents with cystic fibrosis: a systematic review","volume":"137","author":"Andrade Lima","year":"2018","journal-title":"Respir Med"},{"key":"2024102403540491000_30.160.200354.66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/resp.12379","article-title":"Development and psychometric validation of a cystic fibrosis knowledge scale","volume":"19","author":"Balfour","year":"2014","journal-title":"Respirology"},{"key":"2024102403540491000_30.160.200354.67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12890-019-0887-6","article-title":"Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study","volume":"19","author":"Bell","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024102403540491000_30.160.200354.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.01.006"},{"key":"2024102403540491000_30.160.200354.69","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026175115318"},{"key":"2024102403540491000_30.160.200354.70","doi-asserted-by":"crossref","first-page":"e0225004","DOI":"10.1371\/journal.pone.0225004","article-title":"Assessing gastro-intestinal related quality of life in cystic fibrosis: validation of PedsQL GI in children and their parents","volume":"14","author":"Boon","year":"2019","journal-title":"PLoS One"},{"key":"2024102403540491000_30.160.200354.71","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026437214170"},{"key":"2024102403540491000_30.160.200354.72","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ppul.23301","article-title":"An impulse oscillometry system is less efficient than spirometry in tracking lung function improvements after intravenous antibiotic therapy in pediatric patients with cystic fibrosis","volume":"50","author":"Buchs","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2024102403540491000_30.160.200354.73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00247-013-2848-1","article-title":"Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease","volume":"44","author":"Cleveland","year":"2014","journal-title":"Pediatr Radiol"},{"key":"2024102403540491000_30.160.200354.74","first-page":"986","article-title":"Clinical utility of measures of breathlessness","volume":"47","author":"Cullen","year":"2002","journal-title":"Respir Care"},{"key":"2024102403540491000_30.160.200354.75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1590\/0104-1169.3450.2485","article-title":"Validity of the DISABKIDS-Cystic Fibrosis Module for Brazilian children and adolescents","volume":"22","author":"dos Santos","year":"2014","journal-title":"Rev Lat Am Enfermagem"},{"key":"2024102403540491000_30.160.200354.76","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23149"},{"key":"2024102403540491000_30.160.200354.77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcf.2017.12.008","article-title":"Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0\u201311 years","volume":"17","author":"Edwards","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.78","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-9-55"},{"key":"2024102403540491000_30.160.200354.79","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.11.946"},{"key":"2024102403540491000_30.160.200354.80","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(02)00079-6"},{"key":"2024102403540491000_30.160.200354.81","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016711704283"},{"key":"2024102403540491000_30.160.200354.82","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.1.42"},{"key":"2024102403540491000_30.160.200354.83","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.apmr.2009.12.008","article-title":"Use of the peak heart rate reached during six-minute walk test to predict individualized training intensity in patients with cystic fibrosis: validity and reliability","volume":"91","author":"Gruet","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"2024102403540491000_30.160.200354.84","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04821"},{"key":"2024102403540491000_30.160.200354.85","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.healun.2015.03.005","article-title":"Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients","volume":"34","author":"Hoffman","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2024102403540491000_30.160.200354.86","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1586\/17476348.2013.839248","article-title":"Measurement of physical activity in patients with cystic fibrosis: a systematic review","volume":"7","author":"Hulzebos","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"2024102403540491000_30.160.200354.87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pan.2018.11.013","article-title":"Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI)","volume":"19","author":"Johnson","year":"2019","journal-title":"Pancreatology"},{"key":"2024102403540491000_30.160.200354.88","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198903001-00003"},{"key":"2024102403540491000_30.160.200354.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.09.005"},{"key":"2024102403540491000_30.160.200354.90","doi-asserted-by":"publisher","DOI":"10.1177\/1479972316631135"},{"key":"2024102403540491000_30.160.200354.91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcf.2015.03.015","article-title":"Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?","volume":"15","author":"Matecki","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41687-020-00199-5","article-title":"The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis","volume":"4","author":"McCarrier","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"2024102403540491000_30.160.200354.93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcf.2016.08.006","article-title":"Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor","volume":"16","author":"Mesbahi","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.94","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.6.393.31047"},{"key":"2024102403540491000_30.160.200354.95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1157\/13100539","article-title":"[Validity and reliability of the St George's Respiratory Questionnaire in adults with cystic fibrosis]","volume":"43","author":"Padilla","year":"2007","journal-title":"Arch Bronconeumol"},{"key":"2024102403540491000_30.160.200354.96","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-76"},{"key":"2024102403540491000_30.160.200354.97","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2347"},{"key":"2024102403540491000_30.160.200354.98","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-0091-5"},{"key":"2024102403540491000_30.160.200354.99","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcf.2011.12.002","article-title":"Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state","volume":"11","author":"Quon","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcf.2017.01.012","article-title":"The 1-min sit-to-stand test in cystic fibrosis \u2013 insights into cardiorespiratory responses","volume":"16","author":"Radtke","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcf.2015.08.006","article-title":"The 1-min sit-to-stand test \u2013 a simple functional capacity test in cystic fibrosis?","volume":"15","author":"Radtke","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.102","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201501-0061OC"},{"key":"2024102403540491000_30.160.200354.103","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200703-044BR"},{"key":"2024102403540491000_30.160.200354.104","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphar.2012.00038","article-title":"Do patient-reported outcomes have a role in the management of patients with cystic fibrosis?","volume":"3","author":"Salek","year":"2012","journal-title":"Front Pharmacol"},{"key":"2024102403540491000_30.160.200354.105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.06.005"},{"key":"2024102403540491000_30.160.200354.106","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05638"},{"key":"2024102403540491000_30.160.200354.107","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-007-9188-2"},{"key":"2024102403540491000_30.160.200354.108","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950170204"},{"key":"2024102403540491000_30.160.200354.109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jcf.2017.04.011","article-title":"A multiple reader scoring system for nasal potential difference parameters","volume":"16","author":"Solomon","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcf.2016.05.014","article-title":"Physiologic endpoints for clinical studies for cystic fibrosis","volume":"15","author":"Stanojevic","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2016.12.008","article-title":"Chest imaging in cystic fibrosis studies: what counts, and can be counted?","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.112","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/DBP.0b013e3182905646","article-title":"Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health","volume":"34","author":"Tluczek","year":"2013","journal-title":"J Develop Behav Pediatr"},{"key":"2024102403540491000_30.160.200354.113","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcf.2016.12.001","article-title":"Differences between WHO and CDC early growth measurements in the assessment of Cystic Fibrosis clinical outcomes","volume":"16","author":"Usatin","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.114","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2017.04.004","article-title":"Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis","volume":"16","author":"VanDevanter","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2016.11.011","article-title":"The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis: a preliminary study","volume":"16","author":"Ward","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1021799123288","article-title":"Body image in cystic fibrosis \u2013 development of a brief diagnostic scale","volume":"26","author":"Wenninger","year":"2003","journal-title":"J Behav Med"},{"key":"2024102403540491000_30.160.200354.117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1477-7525-9-105","article-title":"Reliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosis","volume":"9","author":"Yohannes","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"2024102403540491000_30.160.200354.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.06.011"},{"key":"2024102403540491000_30.160.200354.119","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04821"},{"key":"2024102403540491000_30.160.200354.120","unstructured":"U.S. National Library of Medicine. Clinical Trials Register. www.clinicaltrials.gov\/ Date last accessed: 2 October 2020."},{"key":"2024102403540491000_30.160.200354.121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF03040902","article-title":"Cystic fibrosis and lung transplantation \u2013 determination of the survival benefit","volume":"116","author":"Aigner","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"2024102403540491000_30.160.200354.122","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.63.1.24","article-title":"The chest roentgenogram in cystic fibrosis: a new scoring system","volume":"63","author":"Brasfield","year":"1979","journal-title":"Pediatrics"},{"key":"2024102403540491000_30.160.200354.123","doi-asserted-by":"publisher","DOI":"10.1007\/BF01314939"},{"key":"2024102403540491000_30.160.200354.124","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.9.860"},{"key":"2024102403540491000_30.160.200354.125","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1404"},{"key":"2024102403540491000_30.160.200354.126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204303261804"},{"key":"2024102403540491000_30.160.200354.127","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.4.345"},{"key":"2024102403540491000_30.160.200354.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.07.008"},{"key":"2024102403540491000_30.160.200354.129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.91.2.488","article-title":"Wisconsin cystic fibrosis chest radiograph scoring system","volume":"91","author":"Weatherly","year":"1993","journal-title":"Pediatrics (Evanston)"},{"key":"2024102403540491000_30.160.200354.130","unstructured":"American Thoracic Society. Cystic Fibrosis Questionnaire (CFQ) and Cystic Fibrosis Questionnaire Revised (CFQ-R). https:\/\/qol.thoracic.org\/sections\/instruments\/ae\/pages\/cfq-cfq-r.html Date last updated: April 2002; date last accessed: 29 September 2020."},{"key":"2024102403540491000_30.160.200354.131","unstructured":"U.S. Food and Drug Administration. Table of surrogate endpoints that were the basis of drug approval or licensure. www.fda.gov\/drugs\/development-resources\/table-surrogate-endpoints-were-basis-drug-approval-or-licensure Date last updated: 20 August 2020; date last accessed: 27 September 2020."},{"key":"2024102403540491000_30.160.200354.132","unstructured":"European Medicines Agency. Report of the workshop on endpoints for cystic fibrosis clinical trials. www.ema.europa.eu\/en\/documents\/report\/report-workshop-endpoints-cystic-fibrosis-clinical-trials_en.pdf Date last updated: 29 November 2012; date last accessed: 13 October 2020."},{"key":"2024102403540491000_30.160.200354.133","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23091"},{"key":"2024102403540491000_30.160.200354.134","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022037320039"},{"key":"2024102403540491000_30.160.200354.135","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033867"},{"key":"2024102403540491000_30.160.200354.136","unstructured":"COSMIN. www.cosmin.nl\/"},{"key":"2024102403540491000_30.160.200354.137","unstructured":"US Department of Health and Human Services. Multiple Endpoints for Clinical Trials: Guidance for Industry. www.fda.gov\/media\/102657\/download Date last updated: January 2017; date last accessed: 15 October 2020."},{"key":"2024102403540491000_30.160.200354.138","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2024102403540491000_30.160.200354.139","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2018 Annual Data Report. Bethesda, MD, National Institutes of Health, 2018."},{"key":"2024102403540491000_30.160.200354.140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.141","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.012113"},{"key":"2024102403540491000_30.160.200354.142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"2024102403540491000_30.160.200354.143","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S2213-2600(16)30121-7","article-title":"Efficacy and safety of lumacaftor\/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup","volume":"4","author":"Elborn","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102403540491000_30.160.200354.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.03.009"},{"key":"2024102403540491000_30.160.200354.145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5409\/wjcp.v8.i2.15","article-title":"Applications of lung clearance index in monitoring children with cystic fibrosis","volume":"8","author":"Fretzayas","year":"2019","journal-title":"World J Clin Pediatr"},{"key":"2024102403540491000_30.160.200354.146","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2019.02.007","article-title":"Abnormal preschool Lung Clearance Index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis","volume":"18","author":"Hardaker","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024102403540491000_30.160.200354.147","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ppul.24498","article-title":"Airway disease on chest computed tomography of preschool children with cystic fibrosis is associated with school aged bronchiectasis","volume":"55","author":"Bouma N","year":"2020","journal-title":"Pediatr Pulmonol"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0354-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:03:00Z","timestamp":1740373380000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0354-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":147,"journal-issue":{"issue":"160","published-online":{"date-parts":[[2021,5,11]]},"published-print":{"date-parts":[[2021,6,30]]}},"alternative-id":["10.1183\/16000617.0354-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0354-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}